A Case Report: Dapsone for the Treatment of Recalcitrant Generalized Pruritic Tense Bullae

Authors

  • Suphattra Trakanwittayarak DEPARTMENT OF DERMATOLOGY, FACULTY OF MEDICINE SIRIRAJ HOSPITAL, MAHIDOL UNIVERSITY, BANGKOK, THAILAND.
  • Chuda Rujitharanawong DEPARTMENT OF DERMATOLOGY, FACULTY OF MEDICINE SIRIRAJ HOSPITAL, MAHIDOL UNIVERSITY, BANGKOK, THAILAND.

Keywords:

anti-p200 pemphigoid, subepidermal autoimmune bullous disease

Abstract

Anti-p200 pemphigoid is a rare subepidermal autoimmune bullous disease. The clinical presentations of anti-p200 pemphigoid are multiple bullae or vesicles with erosions localized on extremities and trunk. Mucosal involvement is reported in some patients. The lesions usually resolved without scar or milia formation. The diagnosis of anti-p200 pemphigoid is challenging. The clinical features, histopathologic findings and immunofluorescence studies of this condition are similar to other autoimmune subepidermal bullous diseases. Although the diagnosis of anti-p200 pemphigoid is confirmed by immunoblotting technique to detect 200-kDa protein autoantibodies, no laboratory service is available as routine in Thailand. Therefore, the diagnosis of anti-p200 pemphigoid should be performed by exclusion of other autoimmune blister diseases.

References

Zillikens D, Kawahara Y, Ishiko A, et al. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 1996;106:465-70.

Goletz S, Hashimoto T, Zillikens D, Schmidt E. Anti-p200 pemphigoid. J Am Acad Dermatol 2014;71:185-91.

Kridin K. Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations. Immunol Res 2018;66:6-17.

Wozniak K, Hashimoto T, Fukuda S, et al. IgA anti-p200 pemphigoid. Arch Dermatol 2011;147:1306-10.

Rousseau L, Droitcourt C, Ropars N, Lelong B, Saillard C, Dupuy A. Successful treatment of severe anti-p200 pemphigoid in a heart transplant recipient with a single cycle of rituximab. JAAD Case Rep 2017;3:175-7.

Laufer Britva R, Amber KT, Cohen AD, Kridin K. Treatment and clinical outcomes in anti-p200 pemphigoid: a systematic review. J Eur Acad Dermatol Venereol 2020;34:465-72.

Van Lerberghe L, Lasek A, Gosset P, Jouen F, Modiano P. Anti-p200 pemphigoid responding to dapsone. Dermatologica Sinica 2014;32:51-4.

Commin MH, Schmidt E, Duvert-Lehembre S, et al. Clinical and immunological features and outcome of anti-p200 pemphigoid. Br J Dermatol 2016;175:776-81.

Fujimoto W, Hamada T, Yamada J, Matsuura H, Iwatsuki K. Bullous Systemic Lupus Erythematosus as an Initial Manifestation of SLE. J Dermatol 2005;32:1021-7.

Sprow G, Afarideh M, Dan J, Hedberg ML, Werth VP. Bullous systemic lupus erythematosus in females. Int J Womens Dermatol 2022;8:e034.

Sueki H, Sato Y, Ohtoshi S, et al. A case of subepidermal blistering disease with autoantibodies to multiple laminin subunits who developed later autoantibodies to alpha-5 chain of type IV collagen associated with membranous glomerulonephropathy. Acta Derm Venereol 2015;95:826-9.

Downloads

Published

2022-12-19

How to Cite

Trakanwittayarak, S., & Rujitharanawong, C. . (2022). A Case Report: Dapsone for the Treatment of Recalcitrant Generalized Pruritic Tense Bullae. Thai Journal of Dermatology, 38(4), 146–153. Retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/259155